KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

Trading levels for HCM.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 321.40 10.83 %
R2 311.81 7.52 %
R1 305.89 5.48 %
Current price: 290.00
Support S1 286.71 -1.13 %
S2 280.79 -3.18 %
S3 271.20 -6.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 304.00 4.83 %
R2 296.00 2.07 %
R1 293.00 1.03 %
Current price 290.00
Support S1 289.50 -0.172%
S2 276.00 -4.83%
S3 261.50 -9.83%

HCM.L Predictions History

4 years ago
NameNotImportant predicted that HCM.L for 2019-05-03 is going £3,582.54 (79 689.31%)

5 years ago
NameNotImportant predicted that HCM.L for 2019-04-29 is going £4,447.60 (99 176.79%)

5 years ago
NameNotImportant predicted that HCM.L for 2019-04-23 is going £4,585.13 (100 672.09%)

Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT